The global mesenchymal stem cells market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for stem cell therapy in various therapeutic areas such as cardiovascular diseases, neurological disorders, and cancer. The increasing number of clinical trials and approvals for stem cell therapy are also driving the growth of this market. The human MSC segment accounted for the largest share in 2018 due to its wide range of applications in various therapeutic areas such as cardiovascular diseases, neurological disorders, and cancer. The mouse MSC segment is expected to grow at a CAGR of 9% during the forecast period due to its use in research institutes and hospitals for regenerative medicine therapies. -Mesenchymal stem cells are a type of adult stem cell that can differentiate into many different types of cells, including bone, cartilage, and fat. -Mesenchymal stem cells have been used in clinical trials for the treatment of osteoarthritis and other joint diseases. -The use of mesenchymal stem cells is still in its infancy but has shown promise as a potential therapy for various conditions. -The global market for mesenchymal stem cell therapies is expected to grow at an annual rate of 12% from 2016 to 2020. -In the United States, the FDA has approved two clinical trials using mesenchymal stem cells to treat heart failure patients with reduced ejection fraction (HFrEF).
Industry Growth Insights published a new data on “Mesenchymal Stem Cells Market”. The research report is titled “Mesenchymal Stem Cells Market research by Types (Human MSC, Mouse MSC, Rat MSC, Other, Mesenchymal Stem Cell), By Applications (Research Institute, Hospital, Others), By Players/Companies Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Mesenchymal Stem Cell”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mesenchymal Stem Cells Market Research Report
By Type
Human MSC, Mouse MSC, Rat MSC, Other, Mesenchymal Stem Cell
By Application
Research Institute, Hospital, Others
By Companies
Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Mesenchymal Stem Cell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Mesenchymal Stem Cells Market Report Segments:
The global Mesenchymal Stem Cells market is segmented on the basis of:
Types
Human MSC, Mouse MSC, Rat MSC, Other, Mesenchymal Stem Cell
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institute, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Thermo Fisher
- Bio-Techne
- ATCC
- MilliporeSigma
- PromoCell GmbH
- Genlantis
- Celprogen
- Cell Applications
- Cyagen Biosciences
- Mesenchymal Stem Cell
Highlights of The Mesenchymal Stem Cells Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human MSC
- Mouse MSC
- Rat MSC
- Other
- Mesenchymal Stem Cell
- By Application:
- Research Institute
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mesenchymal Stem Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mesenchymal stem cells are a type of adult stem cell that can differentiate into many different types of cells in the body. These cells can help to repair damaged tissue and may be able to prevent or treat diseases.
Some of the major players in the mesenchymal stem cells market are Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Mesenchymal Stem Cell.
The mesenchymal stem cells market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mesenchymal Stem Cells Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mesenchymal Stem Cells Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mesenchymal Stem Cells Market - Supply Chain
4.5. Global Mesenchymal Stem Cells Market Forecast
4.5.1. Mesenchymal Stem Cells Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mesenchymal Stem Cells Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mesenchymal Stem Cells Market Absolute $ Opportunity
5. Global Mesenchymal Stem Cells Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mesenchymal Stem Cells Market Size and Volume Forecast by Type
5.3.1. Human MSC
5.3.2. Mouse MSC
5.3.3. Rat MSC
5.3.4. Other
5.3.5. Mesenchymal Stem Cell
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mesenchymal Stem Cells Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mesenchymal Stem Cells Market Size and Volume Forecast by Application
6.3.1. Research Institute
6.3.2. Hospital
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mesenchymal Stem Cells Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mesenchymal Stem Cells Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mesenchymal Stem Cells Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mesenchymal Stem Cells Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mesenchymal Stem Cells Demand Share Forecast, 2019-2026
9. North America Mesenchymal Stem Cells Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mesenchymal Stem Cells Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mesenchymal Stem Cells Market Size and Volume Forecast by Application
9.4.1. Research Institute
9.4.2. Hospital
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mesenchymal Stem Cells Market Size and Volume Forecast by Type
9.7.1. Human MSC
9.7.2. Mouse MSC
9.7.3. Rat MSC
9.7.4. Other
9.7.5. Mesenchymal Stem Cell
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mesenchymal Stem Cells Demand Share Forecast, 2019-2026
10. Latin America Mesenchymal Stem Cells Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mesenchymal Stem Cells Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mesenchymal Stem Cells Market Size and Volume Forecast by Application
10.4.1. Research Institute
10.4.2. Hospital
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mesenchymal Stem Cells Market Size and Volume Forecast by Type
10.7.1. Human MSC
10.7.2. Mouse MSC
10.7.3. Rat MSC
10.7.4. Other
10.7.5. Mesenchymal Stem Cell
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mesenchymal Stem Cells Demand Share Forecast, 2019-2026
11. Europe Mesenchymal Stem Cells Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mesenchymal Stem Cells Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mesenchymal Stem Cells Market Size and Volume Forecast by Application
11.4.1. Research Institute
11.4.2. Hospital
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mesenchymal Stem Cells Market Size and Volume Forecast by Type
11.7.1. Human MSC
11.7.2. Mouse MSC
11.7.3. Rat MSC
11.7.4. Other
11.7.5. Mesenchymal Stem Cell
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mesenchymal Stem Cells Demand Share, 2019-2026
12. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mesenchymal Stem Cells Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mesenchymal Stem Cells Market Size and Volume Forecast by Application
12.4.1. Research Institute
12.4.2. Hospital
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mesenchymal Stem Cells Market Size and Volume Forecast by Type
12.7.1. Human MSC
12.7.2. Mouse MSC
12.7.3. Rat MSC
12.7.4. Other
12.7.5. Mesenchymal Stem Cell
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mesenchymal Stem Cells Demand Share, 2019-2026
13. Middle East & Africa Mesenchymal Stem Cells Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mesenchymal Stem Cells Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mesenchymal Stem Cells Market Size and Volume Forecast by Application
13.4.1. Research Institute
13.4.2. Hospital
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mesenchymal Stem Cells Market Size and Volume Forecast by Type
13.7.1. Human MSC
13.7.2. Mouse MSC
13.7.3. Rat MSC
13.7.4. Other
13.7.5. Mesenchymal Stem Cell
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mesenchymal Stem Cells Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mesenchymal Stem Cells Market: Market Share Analysis
14.2. Mesenchymal Stem Cells Distributors and Customers
14.3. Mesenchymal Stem Cells Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Lonza
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Techne
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ATCC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MilliporeSigma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PromoCell GmbH
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Genlantis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Celprogen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cell Applications
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cyagen Biosciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Mesenchymal Stem Cell
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook